查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球 IVD 合同製造市場：按產品類型（消耗品、設備）、技術（免疫測定、臨床化學、分子診斷、微生物學、血液學、止血）和服務（製造、檢測開發）預測到 2028 年
市場調查報告書
商品編碼
1309761

全球 IVD 合同製造市場：按產品類型（消耗品、設備）、技術（免疫測定、臨床化學、分子診斷、微生物學、血液學、止血）和服務（製造、檢測開發）預測到 2028 年

IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 211 Pages | 訂單完成後即時交付

價格
簡介目錄

全球 IVD（體外診斷）合同製造市場規模預計將從 2023 年的 150 億美元增至 2028 年的 255 億美元，預測期內復合年增長率為 11.2%。

市場的主要驅動因素包括內部 IVD 的高成本、IVD 合同製造商採用新技術來實現高效的產品開發，以及主要製造商日益需要將製造外包給 CMO 以減輕製造負擔並專注於開發新技術。

CMO 正在加強其製造活動和先進技術設備的開發，以在這個高度分散的市場中競爭並鞏固其地位。

“IVD設備領域在IVD代工市場中佔有很大份額”

在IVD合同製造市場中，IVD設備細分市場將在2022年佔據更大份額。 預計該細分市場在預測期內將以穩定的複合年增長率增長。 該細分市場的增長主要是由於全球 IVD 測試量的增加以及 COVID-19 大流行後對分子測試設備的需求激增。

“分子診斷領域在預測期內將以最高複合年增長率增長”

從技術角度來看，分子診斷領域在預測期內將以最大的複合年增長率增長。 該領域的增長主要是由於傳染病、癌症和各種遺傳病的患病率不斷上升，以及分子診斷技術在藥物遺傳學和 PoC 測試中的應用不斷增加。 此外，人們對個性化醫療的認識和接受度不斷提高、技術進步以及 MDx 在遺傳病檢測和產前檢測中的應用不斷擴大，預計也將影響市場增長。 PCR 在蛋白質組學和基因組學中的使用增加、儀器自動化以及 qRT-PCR 等先進技術的出現也有望支持市場增長。 ”

“亞太地區在預測期內將以最大的複合年增長率增長”

在預測期內，按地區劃分，亞太地區將以最高的複合年增長率增長。 推動該市場增長的關鍵因素包括大量合同製造商的存在、中國和印度CMO數量的極高增長率、該地區新興市場工廠的製造能力和效率、供應鏈物流的便利性以及高質量設備的成本控制生產。

內容

第一章簡介

第 2 章研究方法

第 3 章執行摘要

第 4 章重要考慮因素

第五章市場概述

  • 簡介
  • 市場動態
    • 驅動程序
    • 制約因素
    • 機會
    • 任務
  • 行業趨勢
  • 波特五力分析
  • 關稅和監管狀況
  • 重大會議和活動（2022-2023）
  • 專利分析
  • 技術分析
  • 供應鏈分析
  • 主要利益相關者和採購標準
  • 生態系統分析
  • 收入來源：轉向基於技術的解決方案
  • IVD 合同製造市場：經濟衰退的影響

第 6 章 IVD 合同製造市場：按產品類型

  • 簡介
  • 消耗品
  • 設備

第 7 章：IVD 合同製造市場：按技術

  • 簡介
  • 免疫分析
  • 臨床化學
  • 分子診斷
  • 驗血
  • 微生物測試
  • 凝血及止血試驗
  • 其他技術

第 8 章：IVD 合同製造市場：按服務類型

  • 簡介
  • 製造服務
  • 檢測開發
  • 其他服務

第 9 章 IVD 合同製造市場：按地區

  • 簡介
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 亞太地區其他地區
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲

第 10 章競爭格局

  • 概述
  • 公司採取的主要策略
  • 頂級公司的收入份額分析
  • 市場份額分析
  • 企業評估矩陣（2022 年）
  • 競爭基準測試
  • 競爭場景

第 11 章公司簡介

  • 主要公司
    • JABIL INC.
    • SANMINA CORPORATION
    • TE CONNECTIVITY
    • CELESTICA, INC.
    • WEST PHARMACEUTICAL SERVICES, INC.
    • SAVYON DIAGNOSTICS, LTD.
    • KMC SYSTEMS
    • CENOGENICS CORPORATION
    • NOVA BIOMEDICAL
    • CONE BIOPRODUCTS
    • INVETECH
    • AVIOQ, INC.
    • MERIDIAN BIOSCIENCE, INC.
    • KIMBALL ELECTRONICS, INC.
    • NEMERA
    • VIANT MEDICAL HOLDINGS, INC.
    • PHILLIPS-MEDISIZE CORPORATION
    • NOLATO GW, INC.
    • STRATEC SE
    • THERMO FISHER SCIENTIFIC, INC.
    • FUJIREBIO
    • BIOKIT (WERFEN)
  • 其他企業
    • AFFINITY LIFESCIENCE
    • SEKISUI
    • PRESTIGE DIAGNOSTICS

第12章 附錄

簡介目錄
Product Code: MD 8700

The global IVD contract manufacturing market is projected to reach USD 25.5 billion by 2028 from USD 15.0 billion in 2023, at a CAGR of 11.2% during the forecast period. The high cost associated with in-house manufactured IVD products, the adoption of new technology to develop efficient products by IVD contract manufacturers, and the increased need to outsource manufacturing to CMOs by large manufacturers to reduce the manufacturing burden and focus on the development of newer technology.

There has been increased manufacturing activities and development by CMOs of advanced technological equipments to compete in this highly fragmented market and strengthen its position.

"IVD Equipment segment accounted for a larger share of the IVD contract manufacturing market"

In 2022, the IVD equipment segment accounted for a larger share of the IVD contract manufacturing market. This segment is also estimated to grow at a stable CAGR during the forecast period. Growth in this segment can primarily be attributed to the increasing volume of IVD tests performed globally and need burst of molecular test equipment post the Covid-19 pandemic.

"The molecular diagnostic segment will grow at highest CAGR during the forecast period"

Based on technology, the molecular diagnostic segment will grow at highest CAGR during the forecast period. Growth in this segment can primarily be attributed to the rising prevalence of infectious diseases, cancer, and various genetic disorders, increasing applications of molecular diagnostic technologies in pharmacogenetics and point-of-care testing. Moreover, the increasing awareness and acceptance of personalized medicine, technological advancements, and the growing application of MDx in hereditary disease testing & prenatal testing is also likely to influence the market growth. The growing use of PCR in proteomics and genomics, automation of instruments, and the emergence of advanced technologies such as qRT-PCR is also likely to support the growth of the market"

"Asia Pacific will grow at highest CAGR during the forecast period"

In 2022, Asia Pacific will grow at highest CAGR during the forecast period. Major factors driving the growth of this market are the presence of large numebr of conntract manufacturers, the rise in number of CMOs in China and India at an exobidantly high rate, the manufacturing capabilites and effienciency of the development plants in this region, ease of supply chain logistics, and cost controlled production of high quality equipments.

The break-up of the profile of primary participants in the IVD contract manufacturing market:

  • By Company Type: Tier 1 - 34%, Tier 2 - 38%, and Tier 3 - 28%
  • By Designation: C Level - 26%, Director Level - 35%, Others-39%
  • By Region: Asia Pacific - 39%, North America - 28%, Europe -17%, Latin America - 9%
  • Middle East - 7%

The prominent players in the IVD contract manufacturing market include Jabil Inc. (US), Sanmina Corporation (US), TE Connectivity (Switzerland), Celestica Inc.(Canada),Thermofisher (US) Savyon Diagnostics (Israel),

Research Coverage:

The report analyzes the IVD contract manufacturing market and aims at estimating the market size and future growth potential of this market based on various segments such as device type, technology, service and region. The report also includes a product portfolio matrix of various IVD contract manufactured equipment or consumables available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall IVD contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (high cost effective manufacturing of high technological and patented technology), restraints (risk to OEMs intellectual property and quality control), opportunities (high growth in developing countries), and challenges (shortage of skilled labour) influencing the growth of the IVD contract manufacturing market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the IVD contract manufacturing market
  • Market Development: Comprehensive information on the lucrative emerging markets by type, application, end user and region.
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global IVD contract manufacturing market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Jabil Inc. (US), Sanmina Corporation (US), TE Connectivity (Switzerland), Celestica Inc.(Canada), Savyon Diagnostics (Israel), Thermofisher (US) in the global IVD contract manufacturing market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 IVD CONTRACT MANUFACTURING MARKET SEGMENTATION
    • FIGURE 2 IVD CONTRACT MANUFACTURING MARKET: REGIONAL SEGMENTATION
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 4 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
    • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END-USER, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: JABIL INC.
    • FIGURE 10 SUPPLY-SIDE ANALYSIS: IVD CONTRACT MANUFACTURING MARKET (2022)
    • FIGURE 11 DEMAND-SIDE ESTIMATION FOR IVD CONTRACT MANUFACTURING MARKET
    • FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
    • FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.2.1 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 LIMITATIONS & RISK ASSESSMENT
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
    • 2.6.3 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: IVD CONTRACT MANUFACTURING MARKET
  • 2.7 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 15 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 17 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 18 IVD CONTRACT MANUFACTURING MARKET: GEOGRAPHICAL SNAPSHOT, 2022

4 PREMIUM INSIGHTS

  • 4.1 IVD CONTRACT MANUFACTURING MARKET OVERVIEW
    • FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN IVD TO DRIVE MARKET
  • 4.2 IVD CONTRACT MANUFACTURING MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.3 IVD CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.4 IVD CONTRACT MANUFACTURING MARKET: REGIONAL MIX
    • FIGURE 22 ASIA PACIFIC TO DOMINATE MARKET IN 2028

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 23 MARKET DYNAMICS: IVD CONTRACT MANUFACTURING MARKET
    • TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing outsourcing activity by IVD manufacturers
      • 5.2.1.2 High cost of in-house IVD manufacturing
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 IP protection concerns and possibility of theft
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth potential of emerging economies
    • FIGURE 24 ASIA PACIFIC: HEALTHCARE EXPENDITURE, 2010-2020 (% OF GDP)
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of skilled labor
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES
    • 5.3.2 MICROFLUIDICS-BASED POC AND LAB-ON-A-CHIP DIAGNOSTIC DEVICES FOR LABORATORY TESTING
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 25 IVD CONTRACT MANUFACTURING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 IVD CONTRACT MANUFACTURING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 THREAT OF SUBSTITUTES
    • 5.4.2 BARGAINING POWER OF SUPPLIERS
    • 5.4.3 INTENSITY OF COMPETITIVE RIVALRY
    • 5.4.4 BARGAINING POWER OF BUYERS
    • 5.4.5 THREAT OF NEW ENTRANTS
  • 5.5 TARIFF AND REGULATORY LANDSCAPE
    • 5.5.1 REGULATORY ANALYSIS
      • 5.5.1.1 North America
        • 5.5.1.1.1 US
    • TABLE 5 US: CLASSIFICATION OF MEDICAL EQUIPMENT
    • TABLE 6 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • 5.5.1.1.2 Canada
    • TABLE 7 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.5.1.2 Europe
    • TABLE 8 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • FIGURE 26 EUROPE: IVDR TIMELINE
      • 5.5.1.3 Asia Pacific
        • 5.5.1.3.1 Japan
    • FIGURE 27 REGULATORY PROCESS FOR IVD DEVICES IN JAPAN
    • TABLE 9 JAPAN: CLASSIFICATION OF IVD REAGENTS IN JAPAN
    • TABLE 10 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • 5.5.1.3.2 China
    • TABLE 11 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • 5.5.1.3.3 India
    • FIGURE 28 INDIA: REGULATORY PROCESS FOR IVD DEVICES
      • 5.5.1.4 South Korea
    • TABLE 12 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.6 KEY CONFERENCES AND EVENTS IN 2022-2023
    • TABLE 18 IVD CONTRACT MANUFACTURING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.7 PATENT ANALYSIS
    • 5.7.1 PATENT PUBLICATION TRENDS FOR IVD DEVICES
    • FIGURE 29 PATENT PUBLICATION TRENDS (JANUARY 2013-JULY 2023)
    • 5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR IVD DEVICES PATENTS (JANUARY 2013-JULY 2023)
    • FIGURE 31 TOP 10 APPLICANT COUNTRIES/REGIONS FOR IVD DEVICES PATENTS (JANUARY 2013-JULY 2023)
    • 5.7.3 PATENT PUBLICATION TRENDS FOR IVD DEVICES
    • TABLE 19 IVD DEVICES: LIST OF MAJOR PATENTS
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 KEY TECHNOLOGIES: IVD CONTRACT MANUFACTURING MARKET
    • 5.8.2 ADJACENT TECHNOLOGIES
  • 5.9 SUPPLY CHAIN ANALYSIS
    • FIGURE 32 IVD CONTRACT MANUFACTURING MARKET: SUPPLY CHAIN (2022)
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF IVD PRODUCTS
    • 5.10.2 BUYING CRITERIA
    • FIGURE 34 KEY BUYING CRITERIA FOR IVD PRODUCTS
    • TABLE 20 KEY BUYING CRITERIA FOR IVD PRODUCTS
  • 5.11 ECOSYSTEM ANALYSIS
    • FIGURE 35 IVD CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS (2022)
  • 5.12 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS
    • FIGURE 36 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS
  • 5.13 IVD CONTRACT MANUFACTURING MARKET: RECESSION IMPACT

6 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE

  • 6.1 INTRODUCTION
    • TABLE 21 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • 6.2 CONSUMABLES
    • 6.2.1 CONSUMABLES TO DOMINATE IVD CONTRACT MANUFACTURING MARKET
    • TABLE 22 IVD CONTRACT MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 EQUIPMENT
    • 6.3.1 AUTOMATION, ADVANCEMENTS, AND EMPHASIS ON EFFICIENT DIAGNOSTICS TO DRIVE MARKET
    • TABLE 23 IVD CONTRACT MANUFACTURING MARKET FOR EQUIPMENT, BY COUNTRY, 2021-2028 (USD MILLION)

7 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 24 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 7.2 IMMUNOASSAYS
  • 7.3 RISING PREVALENCE OF CANCER TO DRIVE GROWTH
    • TABLE 25 IVD CONTRACT MANUFACTURING MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 CLINICAL CHEMISTRY
    • 7.4.1 GROWING INCIDENCE OF LIFESTYLE DISEASES TO DRIVE DEMAND FOR CLINICAL CHEMISTRY ASSAY TESTING
    • TABLE 26 IVD CONTRACT MANUFACTURING MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 MOLECULAR DIAGNOSTICS
    • 7.5.1 TECHNOLOGICAL INNOVATION IN PCR TESTING TO BOOST GROWTH
    • TABLE 27 IVD CONTRACT MANUFACTURING MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.6 HEMATOLOGY
    • 7.6.1 RISING ADOPTION OF AUTOMATED HEMATOLOGY ANALYZERS TO DRIVE MARKET
    • TABLE 28 IVD CONTRACT MANUFACTURING MARKET FOR HEMATOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.7 MICROBIOLOGY
    • 7.7.1 RISING PREVALENCE OF MICROBIAL INFECTIONS TO DRIVE MARKET
    • TABLE 29 IVD CONTRACT MANUFACTURING MARKET FOR MICROBIOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.8 COAGULATION & HEMOSTASIS
    • 7.8.1 GROWING USE OF ANTICOAGULATION THERAPY IN SURGICAL PROCEDURES TO DRIVE MARKET
    • TABLE 30 IVD CONTRACT MANUFACTURING MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.9 OTHER TECHNOLOGIES
    • TABLE 31 IVD CONTRACT MANUFACTURING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

8 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE

  • 8.1 INTRODUCTION
    • TABLE 32 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
  • 8.2 MANUFACTURING SERVICES
    • 8.2.1 MANUFACTURING SERVICES TO HOLD LARGEST MARKET SHARE TILL 2028
    • TABLE 33 MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 ASSAY DEVELOPMENT
    • 8.3.1 LOW-COST SETUP, EFFICIENCY, AND HIGH THROUGHPUT TO DRIVE DEMAND FOR ASSAY DEVELOPMENT
    • TABLE 34 ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 OTHER SERVICES
    • TABLE 35 OTHER SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

9 IVD CONTRACT MANUFACTURING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 37 IVD CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 36 IVD CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 ASIA PACIFIC
    • 9.2.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 38 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET SNAPSHOT
    • TABLE 37 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 39 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 40 ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.2.2 CHINA
      • 9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market
    • TABLE 41 CHINA: KEY MACROINDICATORS
    • TABLE 42 CHINA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 43 CHINA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 44 CHINA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.2.3 JAPAN
      • 9.2.3.1 Universal healthcare reimbursement policies to propel market
    • TABLE 45 JAPAN: KEY MACROINDICATORS
    • TABLE 46 JAPAN: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 47 JAPAN: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 48 JAPAN: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.2.4 INDIA
      • 9.2.4.1 Rising contract manufacturing capabilities to support growth
    • TABLE 49 INDIA: KEY MACROINDICATORS
    • TABLE 50 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 51 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 52 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.2.5 AUSTRALIA
      • 9.2.5.1 Need for advanced medical and diagnostic tools to fuel growth
    • TABLE 53 AUSTRALIA: KEY MACROINDICATORS
    • TABLE 54 AUSTRALIA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 55 AUSTRALIA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 56 AUSTRALIA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.2.6 SOUTH KOREA
      • 9.2.6.1 Rising spending on innovative IVD technologies to support market growth
    • TABLE 57 SOUTH KOREA: KEY MACROINDICATORS
    • TABLE 58 SOUTH KOREA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 59 SOUTH KOREA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 60 SOUTH KOREA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.2.7 REST OF ASIA PACIFIC
    • TABLE 61 REST OF ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 62 REST OF ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 REST OF ASIA PACIFIC: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 9.3 NORTH AMERICA
    • 9.3.1 NORTH AMERICA: RECESSION IMPACT
    • TABLE 64 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 66 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 67 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.3.2 US
      • 9.3.2.1 Increasing in-house manufacturing costs to encourage shift to contract manufacturing
    • TABLE 68 US: KEY MACROINDICATORS
    • TABLE 69 US: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 70 US: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 71 US: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.3.3 CANADA
      • 9.3.3.1 Strong presence of key contract manufacturing companies to drive market
    • TABLE 72 CANADA: KEY MACROINDICATORS
    • TABLE 73 CANADA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 74 CANADA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 75 CANADA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 9.4 EUROPE
    • 9.4.1 EUROPE: RECESSION IMPACT
    • TABLE 76 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 77 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 78 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 79 EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.2 GERMANY
      • 9.4.2.1 Germany to hold largest market share
    • TABLE 80 GERMANY: KEY MACROINDICATORS
    • TABLE 81 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 82 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 83 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.3 FRANCE
      • 9.4.3.1 Increasing government pressure to reduce healthcare costs and budgetary constraints
    • TABLE 84 FRANCE: KEY MACROINDICATORS
    • TABLE 85 FRANCE: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 86 FRANCE: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 87 FRANCE: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.4 UK
      • 9.4.4.1 Risng adoption of genome-based testing and increasing accessibility of IVD
    • TABLE 88 UK: KEY MACROINDICATORS
    • TABLE 89 UK: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 UK: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 91 UK: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.5 ITALY
      • 9.4.5.1 Rising incidence of chronic illnesses to drive market
    • TABLE 92 ITALY: KEY MACROINDICATORS
    • TABLE 93 ITALY: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 ITALY: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 95 ITALY: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.6 SPAIN
      • 9.4.6.1 Increasing adoption of home-use medical devices to drive market
    • TABLE 96 SPAIN: KEY MACROINDICATORS
    • TABLE 97 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.4.7 REST OF EUROPE
    • TABLE 100 REST OF EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 101 REST OF EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 REST OF EUROPE: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 103 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 104 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 105 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.5.2 MEXICO
      • 9.5.2.1 Mexico to hold largest share of Latin American market
    • TABLE 107 MEXICO: KEY MACROINDICATORS
    • TABLE 108 MEXICO: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 109 MEXICO: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 110 MEXICO: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.5.3 BRAZIL
      • 9.5.3.1 Favorable government initiatives and willingness to pay for better healthcare to drive market
    • TABLE 111 BRAZIL: KEY MACROINDICATORS
    • TABLE 112 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • 9.5.4 REST OF LATIN AMERICA
    • TABLE 115 REST OF LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 116 REST OF LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 117 REST OF LATIN AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING HEALTHCARE INVESTMENTS AND INFRASTRUCTURAL IMPROVEMENTS TO DRIVE MARKET
    • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 118 MIDDLE EAST & AFRICA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 MIDDLE EAST & AFRICA: IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 MIDDLE EAST & AFRICA: IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY STRATEGIES ADOPTED BY PLAYERS
  • 10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 39 TOP MARKET PLAYERS DOMINATE IVD CONTRACT MANUFACTURING MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 40 IVD CONTRACT MANUFACTURING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
  • 10.5 COMPANY EVALUATION MATRIX, 2022
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 41 IVD CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION QUADRANT (2022)
  • 10.6 COMPETITIVE BENCHMARKING
    • TABLE 121 OVERALL COMPANY FOOTPRINT
    • TABLE 122 OMPANY FOOTPRINT ANALYSIS, BY PRODUCT TYPE
    • TABLE 123 COMPANY FOOTPRINT ANALYSIS, BY SERVICE TYPE
    • TABLE 124 COMPANY FOOTPRINT ANALYSIS, BY REGION
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 PRODUCT LAUNCHES
    • TABLE 125 PRODUCT LAUNCHES (JANUARY 2020-MAY 2023)
    • 10.7.2 DEALS
    • TABLE 126 DEALS (JANUARY 2020-MAY 2023)
    • 10.7.3 OTHER DEVELOPMENTS
    • TABLE 127 OTHER DEVELOPMENTS (JANUARY 2020-MAY 2023)

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 JABIL INC.
    • TABLE 128 JABIL INC.: COMPANY OVERVIEW
    • FIGURE 42 JABIL INC.: COMPANY SNAPSHOT (2022)
    • 11.1.2 SANMINA CORPORATION
    • TABLE 129 SANMINA CORPORATION: COMPANY OVERVIEW
    • FIGURE 43 SANMINA CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.3 TE CONNECTIVITY
    • TABLE 130 TE CONNECTIVITY: COMPANY OVERVIEW
    • FIGURE 44 TE CONNECTIVITY: COMPANY SNAPSHOT (2022)
    • 11.1.4 CELESTICA, INC.
    • TABLE 131 CELESTICA, INC.: COMPANY OVERVIEW
    • FIGURE 45 CELESTICA, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.5 WEST PHARMACEUTICAL SERVICES, INC.
    • TABLE 132 WEST PHARMACEUTICALS SERVICES, INC.: COMPANY OVERVIEW
    • FIGURE 46 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.6 SAVYON DIAGNOSTICS, LTD.
    • TABLE 133 SAVYON DIAGNOSTICS, LTD.: COMPANY OVERVIEW
    • 11.1.7 KMC SYSTEMS
    • TABLE 134 KMC SYSTEMS: COMPANY OVERVIEW
    • FIGURE 47 ELBIT SYSTEMS: COMPANY SNAPSHOT (2022)
    • 11.1.8 CENOGENICS CORPORATION
    • TABLE 135 CENOGENICS CORPORATION: COMPANY OVERVIEW
    • 11.1.9 NOVA BIOMEDICAL
    • TABLE 136 NOVA BIOMEDICAL: COMPANY OVERVIEW
    • 11.1.10 CONE BIOPRODUCTS
    • TABLE 137 CORE BIOPRODUCTS: COMPANY OVERVIEW
    • 11.1.11 INVETECH
    • TABLE 138 INVETECH: COMPANY OVERVIEW
    • FIGURE 48 FORTIVE: COMPANY SNAPSHOT (2022)
    • 11.1.12 AVIOQ, INC.
    • TABLE 139 AVIOQ, INC.: COMPANY OVERVIEW
    • 11.1.13 MERIDIAN BIOSCIENCE, INC.
    • TABLE 140 MERIDIAN BIOSCIENCE, INC.: COMPANY OVERVIEW
    • FIGURE 49 MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.14 KIMBALL ELECTRONICS, INC.
    • TABLE 141 KIMBALL ELECTRONICS, INC.: COMPANY OVERVIEW
    • FIGURE 50 KIMBALL ELECTRONICS, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.15 NEMERA
    • TABLE 142 NEMERA: COMPANY OVERVIEW
    • 11.1.16 VIANT MEDICAL HOLDINGS, INC.
    • TABLE 143 VIANT MEDICAL HOLDINGS, INC.: COMPANY OVERVIEW
    • 11.1.17 PHILLIPS-MEDISIZE CORPORATION
    • TABLE 144 PHILLIPS-MEDISIZE CORPORATION: COMPANY OVERVIEW
    • 11.1.18 NOLATO GW, INC.
    • TABLE 145 NOLATO GW, INC.: COMPANY OVERVIEW
    • FIGURE 51 NOLATO GW, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.19 STRATEC SE
    • TABLE 146 STRATEC SE: COMPANY OVERVIEW
    • FIGURE 52 STRATEC SE: COMPANY SNAPSHOT (2022)
    • 11.1.20 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 147 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
    • FIGURE 53 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.21 FUJIREBIO
    • TABLE 148 FUJIREBIO: COMPANY OVERVIEW
    • FIGURE 54 H.U. GROUP: COMPANY SNAPSHOT (2022)
    • 11.1.22 BIOKIT (WERFEN)
    • TABLE 149 BIOKIT: COMPANY OVERVIEW
    • FIGURE 55 WERFEN: COMPANY SNAPSHOT (2022)
  • 11.2 OTHER COMPANIES
    • 11.2.1 AFFINITY LIFESCIENCE
    • 11.2.2 SEKISUI
    • 11.2.3 PRESTIGE DIAGNOSTICS
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS